Given that angiogenesis plays a key role in the development and metastasis of malignant tumors and the VEGF/VEGFR signaling pathway is exceedingly vital in angiogenesis, the targeted inhibition of this pathway has arisen as one of the important anti-tumor angiogenesis therapeutic strategies [47]. Here, KDR is linked to cancer.